BioHarvest Sciences (BHST) Competitors $5.33 +0.01 (+0.19%) As of 03/10/2025 03:48 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsTrends BHST vs. ESPR, MBX, TERN, ALDX, BNTC, ATAI, SEPN, ANNX, IMMP, and DMACShould you be buying BioHarvest Sciences stock or one of its competitors? The main competitors of BioHarvest Sciences include Esperion Therapeutics (ESPR), MBX Biosciences (MBX), Terns Pharmaceuticals (TERN), Aldeyra Therapeutics (ALDX), Benitec Biopharma (BNTC), Atai Life Sciences (ATAI), Septerna (SEPN), Annexon (ANNX), Immutep (IMMP), and DiaMedica Therapeutics (DMAC). These companies are all part of the "pharmaceutical preparations" industry. BioHarvest Sciences vs. Esperion Therapeutics MBX Biosciences Terns Pharmaceuticals Aldeyra Therapeutics Benitec Biopharma Atai Life Sciences Septerna Annexon Immutep DiaMedica Therapeutics BioHarvest Sciences (NASDAQ:BHST) and Esperion Therapeutics (NASDAQ:ESPR) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, analyst recommendations, valuation, institutional ownership, media sentiment, dividends, earnings, risk and community ranking. Does the MarketBeat Community believe in BHST or ESPR? Esperion Therapeutics received 624 more outperform votes than BioHarvest Sciences when rated by MarketBeat users. However, 100.00% of users gave BioHarvest Sciences an outperform vote while only 70.18% of users gave Esperion Therapeutics an outperform vote. CompanyUnderperformOutperformBioHarvest SciencesOutperform Votes2100.00% Underperform VotesNo VotesEsperion TherapeuticsOutperform Votes62670.18% Underperform Votes26629.82% Do analysts recommend BHST or ESPR? BioHarvest Sciences currently has a consensus price target of $13.00, indicating a potential upside of 143.90%. Esperion Therapeutics has a consensus price target of $6.75, indicating a potential upside of 327.22%. Given Esperion Therapeutics' higher possible upside, analysts clearly believe Esperion Therapeutics is more favorable than BioHarvest Sciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BioHarvest Sciences 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Esperion Therapeutics 1 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.50 Which has more volatility & risk, BHST or ESPR? BioHarvest Sciences has a beta of 2.27, indicating that its stock price is 127% more volatile than the S&P 500. Comparatively, Esperion Therapeutics has a beta of 1.04, indicating that its stock price is 4% more volatile than the S&P 500. Which has preferable earnings & valuation, BHST or ESPR? BioHarvest Sciences has higher earnings, but lower revenue than Esperion Therapeutics. Esperion Therapeutics is trading at a lower price-to-earnings ratio than BioHarvest Sciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBioHarvest Sciences$22.43M3.90-$12.56M-$1.25-4.26Esperion Therapeutics$332.31M0.94-$209.25M-$0.25-6.32 Is BHST or ESPR more profitable? Esperion Therapeutics has a net margin of -29.37% compared to BioHarvest Sciences' net margin of -76.65%. Company Net Margins Return on Equity Return on Assets BioHarvest Sciences-76.65% N/A -85.16% Esperion Therapeutics -29.37%N/A -10.77% Does the media refer more to BHST or ESPR? In the previous week, Esperion Therapeutics had 19 more articles in the media than BioHarvest Sciences. MarketBeat recorded 20 mentions for Esperion Therapeutics and 1 mentions for BioHarvest Sciences. Esperion Therapeutics' average media sentiment score of 0.62 beat BioHarvest Sciences' score of 0.00 indicating that Esperion Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment BioHarvest Sciences 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Esperion Therapeutics 4 Very Positive mention(s) 2 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders & institutionals have more ownership in BHST or ESPR? 47.4% of Esperion Therapeutics shares are held by institutional investors. 1.0% of Esperion Therapeutics shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. SummaryEsperion Therapeutics beats BioHarvest Sciences on 12 of the 17 factors compared between the two stocks. Remove Ads Get BioHarvest Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for BHST and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BHST vs. The Competition Export to ExcelMetricBioHarvest SciencesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$87.55M$7.11B$5.72B$8.00BDividend YieldN/A2.72%4.89%4.03%P/E Ratio-4.276.3024.9018.90Price / Sales3.90219.97401.45115.03Price / CashN/A65.6738.0534.62Price / Book-4.946.387.274.15Net Income-$12.56M$140.25M$3.19B$246.75M7 Day Performance5.96%0.08%-0.85%-2.17%1 Month Performance-10.42%-8.45%-6.83%-9.12%1 Year PerformanceN/A-12.30%11.07%-0.27% BioHarvest Sciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BHSTBioHarvest SciencesN/A$5.33+0.2%$13.00+143.9%N/A$87.55M$22.43M-4.27N/AGap DownHigh Trading VolumeESPREsperion Therapeutics4.4422 of 5 stars$1.70+2.4%$6.75+297.1%-27.9%$334.96M$295.45M-2.66200Analyst RevisionMBXMBX Biosciences2.2036 of 5 stars$9.60-2.2%$37.25+288.0%N/A$320.80MN/A0.0036Lockup ExpirationTERNTerns Pharmaceuticals4.3765 of 5 stars$3.69flat$18.30+395.9%-58.6%$313.43MN/A-3.1340Upcoming EarningsALDXAldeyra Therapeutics1.6327 of 5 stars$5.11-19.4%$10.00+95.7%+82.9%$304.30MN/A0.0015Earnings ReportHigh Trading VolumeBNTCBenitec Biopharma2.5513 of 5 stars$12.71+11.4%$24.43+92.2%+150.9%$298.06M$80,000.00-8.4220Positive NewsATAIAtai Life Sciences3.2889 of 5 stars$1.72+4.2%$9.00+423.3%-32.9%$288.62M$331,000.00-2.1280SEPNSepterna2.3354 of 5 stars$6.47+11.6%$34.00+425.5%N/A$287.29M$981,000.000.00N/AUpcoming EarningsANNXAnnexon2.0218 of 5 stars$2.64+5.6%$15.80+498.5%-47.5%$281.40MN/A-2.5160Earnings ReportAnalyst RevisionIMMPImmutep1.1105 of 5 stars$1.93+1.6%$8.50+340.4%-36.4%$280.93M$5.14M0.002,021News CoveragePositive NewsDMACDiaMedica Therapeutics1.7573 of 5 stars$6.53+2.4%$7.00+7.2%+78.8%$279.23MN/A-11.6620 Remove Ads Related Companies and Tools Related Companies Esperion Therapeutics Competitors MBX Biosciences Competitors Terns Pharmaceuticals Competitors Aldeyra Therapeutics Competitors Benitec Biopharma Competitors Atai Life Sciences Competitors Septerna Competitors Annexon Competitors Immutep Competitors DiaMedica Therapeutics Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:BHST) was last updated on 3/11/2025 by MarketBeat.com Staff From Our PartnersElon Musk Wants to Audit Fort Knox—What It Means for Your RetirementYou can take advantage of the coming tariff-fueled gold melt-up right inside your IRA or 401(k) – 100% TAX-FRE...Colonial Metals | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredTrump doesn’t give a damnPorter Stansberry: “I met with Trump’s biggest backers… they’re scooping up these 10 stocks” I recently met...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredAlert: DOGE goes liveElon will most likely be at the helm of it all. And just days from now, could bring about the biggest econo...Altimetry | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioHarvest Sciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioHarvest Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
